Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Time Course of Motor Improvement by Epidural Stimulation After Spinal Cord Injury: An Interim Analysis of a Phase II Trial

Title: Time Course of Motor Improvement by Epidural Stimulation After Spinal Cord Injury: An Interim Analysis of a Phase II Trial
Authors: Porceban MM; Angelin LG; Gabana E; Prota C; De Byase MEM; Ferreira RJR; Marcon RM; Cristante AF; Greve JMD; Arévalo A; Sitthinamsunwan B; Majeed N; Jarernpratumdee K; Charles H; Lepski GA
Source: Journal of Central Nervous System Disease, Vol 17 (2025)
Publisher Information: SAGE Publishing
Publication Year: 2025
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: Neurology. Diseases of the nervous system; RC346-429
Description: Background Epidural spinal cord stimulation (EES) is a promising intervention for motor rehabilitation after spinal cord injury (SCI), but the extent and trajectory of motor recovery remain unclear. Objective This phase II trial evaluates the acquisition of voluntary movements in paraplegic patients (ASIA A or B) following SCI, assessed by the Fugl-Meyer Lower Extremity (FMA-LE) score and electromyography (EMG). Methods This interim analysis includes five patients implanted with EES and followed for 12 months. The primary outcome was motor recovery, measured by FMA-LE and EMG. Secondary outcomes included balance (Berg Balance Scale), spasticity (Modified Ashworth Scale), pain, autonomic functions, mood, quality of life (WHO-QOL), and safety. Adverse events were monitored. Results The FMA-LE score improved from 36 ± 9 (SD) to 55 ± 2 at 3 months ( P < 0.05), 59 ± 2 at 6 months ( P < 0.05), and 64 ± 4 at 12 months ( P < 0.05). EMG confirmed increased voluntary activation. Balance and spasticity improved, while pain and autonomic functions remained unchanged. Motor gains plateaued after 5 months, reaching 68% above baseline. No serious adverse events occurred, though minor complications included transient nociceptive pain and a self-resolving pressure ulcer. Conclusions These findings support the role of EES in facilitating early motor recovery in SCI patients, consistent with prior studies. However, the plateau effect suggests a limit to long-term gains. Future research should explore strategies to sustain improvements, including regenerative therapies or optimized neuromodulation protocols. Trial registration number: NCT06847295
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.1177/11795735251379220; https://doaj.org/toc/1179-5735; https://doaj.org/article/17327f8c93dc46638327c4bade712445
DOI: 10.1177/11795735251379220
Availability: https://doi.org/10.1177/11795735251379220; https://doaj.org/article/17327f8c93dc46638327c4bade712445
Accession Number: edsbas.EF7CF8D
Database: BASE